EMEA-001939-PIP03-16

Key facts

Active substance
Pexidartinib
Therapeutic area
Oncology
Decision number
P/0044/2019
PIP number
EMEA-001939-PIP03-16
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Treatment of benign soft tissue neoplasms
Route(s) of administration
Oral use
Contact for public enquiries
Daiichi Sankyo Inc

Tel.  +49 8978080
E-mail: service@daiichi-sankyo.eu

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating